{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-122099","form_type":"8-K","ticker":"TVRD","cik":"0001346830","company_name":"Tvardi Therapeutics, Inc.","filed_at":"2024-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.229022+00:00","generated_at":"2026-05-29T19:38:38.347986+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cara Therapeutics gets Nasdaq deficiency for equity ($707K vs $2.5M min); also faces bid-price delisting risk","bullets":["Stockholders' equity of $707,000 at Sep 30, 2024 is below Nasdaq's $2.5 million minimum.","Company has 45 days (by Jan 3, 2025) to submit a compliance plan; Nasdaq may grant up to 180-day extension.","Also has outstanding minimum bid price deficiency; must close at $1.00+ for 10 consecutive days by Jan 27, 2025.","Listing remains effective pending compliance; company evaluating options including reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-122099","json":"https://secwatch.observer/filing/0001104659-24-122099.json","markdown":"https://secwatch.observer/filing/0001104659-24-122099.md","text":"https://secwatch.observer/filing/0001104659-24-122099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924122099/0001104659-24-122099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1346830/000110465924122099/tm2429290d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T19:38:38.347986+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}